Avoro Capital Advisors LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 111 filers reported holding TG THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Avoro Capital Advisors LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$7,872,000
-29.1%
800,000
-20.0%
0.27%
-18.4%
Q4 2019$11,100,000
-43.0%
1,000,000
-78.9%
0.33%
-72.0%
Q4 2018$19,475,000
-17.2%
4,750,000
+13.1%
1.16%
+7.8%
Q3 2018$23,520,000
-63.9%
4,200,031
-15.2%
1.08%
-56.9%
Q2 2018$65,093,000
-12.3%
4,950,031
-5.3%
2.51%
-29.3%
Q1 2018$74,261,000
+174.9%
5,229,619
+58.7%
3.55%
+102.5%
Q4 2017$27,015,0003,294,4631.75%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Jetstream Capital LLC 200,000$7,758,0005.97%
Lion Point Capital, LP 609,128$23,628,0004.08%
RA Capital Management 3,342,743$129,665,0002.08%
Ghost Tree Capital, LLC 180,000$6,982,0001.92%
Nicholas Investment Partners, LP 660,964$25,639,0001.61%
ARDSLEY ADVISORY PARTNERS LP 350,000$13,577,0001.60%
SECTORAL ASSET MANAGEMENT INC 414,949$16,096,0001.30%
Spotlight Asset Group, Inc. 75,000$2,909,0001.12%
ACT CAPITAL MANAGEMENT, LLC 55,000$2,134,0001.10%
Pier Capital, LLC 280,486$10,880,0001.09%
View complete list of TG THERAPEUTICS INC shareholders